American Portfolios Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $491K | Sell |
|
|||||
|
2022
Q2 | $460K | Sell |
|
|||||
|
2022
Q1 | $459K | Buy |
|
|||||
|
2021
Q4 | $177K | Buy |
|
|||||
|
2021
Q3 | $185K | Buy |
|
|||||
|
2021
Q2 | $187K | Sell |
|
|||||
|
2021
Q1 | $226K | Buy |
|
|||||
|
2020
Q4 | $220K | Buy |
|
|||||
|
2020
Q3 | $217K | Buy |
|
|||||
|
2020
Q2 | $59.8K | Sell |
|
|||||
|
2020
Q1 | $44K | Sell |
|
|||||
|
2019
Q4 | $83.7K | Buy |
|
|||||
|
2019
Q3 | $62.7K | Sell |
|
|||||
|
2019
Q2 | $62.4K | Buy |
|
|||||
|
2019
Q1 | $30.8K | Hold |
|
|||||
|
2018
Q4 | $25K | Hold |
|
|||||
|
2018
Q3 | $43K | Buy |
|